The global protein A resin market is projected to reach USD 2.0 billion by 2030 from USD 1.5 billion in 2025, at a CAGR of 6.5% during the forecast period.
Market growth is attributed to increased outsourced services through CDMOs, with major players expanding multi-plant biomanufacturing capacities across developed markets. The global monoclonal antibody (mAb) pipeline is growing, marked by high FDA approvals and new bispecific and antibody-drug conjugate launches. This has helped boost purification requirements among end users, which is expected to increase the market for protein A resin.
“Based on product, bulk resins held the largest share of the protein A resin market in 2024.”
Based on products, the protein A resin market is divided into bulk resin, pre-packed columns, lab-scale columns, and others. Unlike pre-packed formats, bulk resin is the industry standard for high-volume purification processes in stainless-steel column setups. While it requires in-house packing and validation, bulk resin provides a much lower cost per cycle and per gram of purified monoclonal antibody. It is the preferred choice among end users because of its reusability. Most types can support 50 to over 200 cycles, enabling long-term production runs with minimal resin replacement. This feature directly enhances the economic efficiency and productivity goals of commercial manufacturing. All these factors make bulk resin the favored choice in the end-use industries.
“Based on matrix type, the agarose-based protein A resin segment accounted for the largest share during the forecast period.”
The protein A resin market is categorized by matrix type into agarose-based, glass/silica-based, and organic polymer-based varieties. Among these, agarose-based protein A resins represent the largest market share. They are known for their improved durability, stronger mechanical properties, and higher capacity to absorb metal dopants at suitable pH levels. Recent developments in agarose-based resins include next-generation products such as Praesto CH1 and DurA Cycle A50, which offer better durability, increased binding capacity, and improved compatibility with complex antibody formats like bispecifics and fragments. These new products feature engineered ligands with enhanced alkaline resistance, enabling longer reuse and better cost efficiency.
"Based on applications, the monoclonal antibodies purification segment has acquired the largest share in 2024.”
Based on applications, the protein A resin market is divided into mAb purification, Fc-fusion protein purification, and other applications. mAb purification holds the largest share in the protein A resin market mainly because of its established role in large-scale biopharmaceutical manufacturing. mAbs are the most widely produced category of biologic therapeutics, requiring large amounts of protein A resin for the primary capture steps in downstream processing. Protein A resin is preferred due to its Fc region binding specificity and compliance with regulatory standards for product purity and consistency. Moreover, a significant portion of the installed biomanufacturing capacity across pharmaceutical companies and contract manufacturing organizations is dedicated to mAb production, which naturally increases demand for protein A resin in this segment.
“Based on end users, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share in 2024.”
Pharmaceutical and biopharmaceutical companies account for the major share in the protein A resin market due to their role as the primary manufacturers of therapeutic proteins, particularly monoclonal antibodies (mAbs) and Fc-fusion proteins. These companies operate large-scale production facilities where protein A resin is extensively used in downstream purification processes, requiring significant resin volumes to meet commercial supply needs and regulatory compliance standards. Additionally, in-house manufacturing setups within these organizations prioritize consistent supply chains and quality control, further reinforcing direct procurement of protein A resins rather than relying solely on outsourced partners. This structural reliance on protein A resin for core biologics manufacturing activities positions pharmaceutical and biopharmaceutical companies as the dominant end-user segment in the market.
“North America is expected to hold a significant market share in the protein A resin market throughout the forecast period.”
The protein A resin market includes five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America held a significant market share for protein A resin. Its dominant position is due to increased manufacturing capacity, focusing on commercial-scale and clinical trial supply production. Investment trends show that US federal and state support promotes domestic biomanufacturing for pandemic preparedness and reducing reliance on international supply chains. Small- to mid-sized biotech firms are increasingly partnering with CDMOs. These factors have helped North America secure the largest market share in 2024.
A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Directors (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
The key players profiled in the protein A resin market are Danaher Corporation (US), Repligen Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific (US), Agilent Technologies (US), GenScript (China), Bio-Rad Laboratories, Inc. (US), Orochem Technologies Inc. (US), Kaneka Corporation (Japan), Abcam Plc. (UK), Ecolab (US), and Tosoh Biosciences LLC (Japan).
Research Coverage
The research report analyzes the protein A resin market by product, matrix type, source, application, end user, and region. It explores the factors driving market growth, examines the challenges and opportunities faced by various industries, and presents details on the competitive landscape, including market leaders and small to medium-sized enterprises. Additionally, it estimates the revenue generated by different market segments across five regions and includes a micromarket analysis.
Reasons to Buy the Report
The report will help market leaders and new entrants by providing accurate revenue estimates for the protein A resin market and subsegments. It will assist stakeholders in understanding the competitive landscape, enabling them to position their businesses more effectively and develop suitable go-to-market strategies. Additionally, the report offers insights into market dynamics, including key drivers, restraints, challenges, and opportunities.
This report provides insightful data on the following pointers:
• Market Penetration: In-depth coverage of product portfolios offered by the top players in the protein A resin market.
• Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the protein A resin market.
• Market Development: Insightful data on profitable developing areas.
• Market Diversification: Details about recent developments and advancements in the protein A resin market.
• Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors.
圖表清單 List of Tables & Figures
TABLE 1 PROTEIN A RESIN MARKET: INCLUSIONS & EXCLUSIONS 23
TABLE 2 PROTEIN A RESIN MARKET: STUDY ASSUMPTIONS 39
TABLE 3 PROTEIN A RESIN MARKET: RISK ANALYSIS 39
TABLE 4 PROTEIN A RESIN MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 49
TABLE 5 KEY PARAMETERS IMPACTING PRICES FOR PROTEIN A RESIN 53
TABLE 6 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN, BY KEY PLAYER,
2022–2024 (USD) 54
TABLE 7 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN, BY REGION,
2022–2024 (USD) 55
TABLE 8 PROTEIN A RESIN MARKET: ROLE IN ECOSYSTEM 58
TABLE 9 PROTEIN A RESIN MARKET: INNOVATIONS AND PATENT REGISTRATIONS,
2022–2024 63
TABLE 10 IMPORT SCENARIO FOR HS CODE 3504, BY COUNTRY,
2020–2024 (USD THOUSAND) 64
TABLE 11 EXPORT SCENARIO FOR HS CODE 3504, BY COUNTRY,
2020–2024 (USD THOUSAND) 65
TABLE 12 PROTEIN A RESIN: LIST OF KEY CONFERENCES & EVENTS,
JANUARY 2025–DECEMBER 2026 65
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANISATIONS 68
TABLE 18 PROTEIN A RESIN MARKET: PORTER’S FIVE FORCES ANALYSIS 73
TABLE 19 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF PROTEIN A RESIN, BY PRODUCT 75
TABLE 20 KEY BUYING CRITERIA OF PROTEIN A RESIN, BY END USER 76
TABLE 21 PROTEIN A RESIN MARKET: UNMET NEEDS 77
TABLE 22 US ADJUSTED RECIPROCAL TARIFF RATES, 2024 78
TABLE 23 KEY COMPANIES IMPLEMENTING AI/GEN AI IN PROTEIN A RESIN MARKET 80
TABLE 24 PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 83
TABLE 25 PROTEIN A RESIN MARKET FOR BULK RESINS, BY REGION,
2023–2030 (USD MILLION) 84
TABLE 26 PROTEIN A RESIN MARKET FOR PREPACKED COLUMNS, BY REGION,
2023–2030 (USD MILLION) 85
TABLE 27 PROTEIN A RESIN MARKET FOR LAB-SCALE COLUMNS, BY REGION,
2023–2030 (USD MILLION) 86
TABLE 28 PROTEIN A RESIN MARKET FOR OTHER PRODUCTS, BY REGION,
2023–2030 (USD MILLION) 87
TABLE 29 PROTEIN A RESIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 89
TABLE 30 RECOMBINANT PROTEIN A MARKET, BY REGION, 2023–2030 (USD MILLION) 90
TABLE 31 NATURAL PROTEIN A MARKET, BY REGION, 2023–2030 (USD MILLION) 91
TABLE 32 PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023–2030 (USD MILLION) 93
TABLE 33 AGAROSE-BASED PROTEIN A MARKET, BY REGION, 2023–2030 (USD MILLION) 94
TABLE 34 GLASS/SILICA-BASED PROTEIN A MARKET, BY REGION,
2023–2030 (USD MILLION) 95
TABLE 35 ORGANIC POLYMER-BASED PROTEIN A MARKET, BY REGION,
2023–2030 (USD MILLION) 96
TABLE 36 PROTEIN A RESIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 98
TABLE 37 PROTEIN A RESIN MARKET FOR MAB PURIFICATION, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 38 PROTEIN A RESIN MARKET FOR FC-FUSION PURIFICATION, BY REGION,
2023–2030 (USD MILLION) 100
TABLE 39 PROTEIN A RESIN MARKET FOR OTHER APPLICATIONS, BY REGION,
2023–2030 (USD MILLION) 101
TABLE 40 PROTEIN A RESIN MARKET, BY END USER, 2023–2030 (USD MILLION) 103
TABLE 41 PROTEIN A RESIN MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 42 PROTEIN A RESIN MARKET FOR CROS & CDMOS, BY REGION,
2023–2030 (USD MILLION) 105
TABLE 43 PROTEIN A RESIN MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023–2030 (USD MILLION) 106
TABLE 44 PROTEIN A RESIN MARKET FOR OTHER END USERS, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 45 PROTEIN A RESIN MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 46 NORTH AMERICA: KEY MACROINDICATORS 111
TABLE 47 NORTH AMERICA: PROTEIN A RESIN MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 48 NORTH AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 111
TABLE 49 NORTH AMERICA: PROTEIN A RESIN MARKET, BY SOURCE,
2023–2030 (USD MILLION) 112
TABLE 50 NORTH AMERICA: PROTEIN A RESIN MARKET, BY MATRIX TYPE,
2023–2030 (USD MILLION) 112
TABLE 51 NORTH AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 112
TABLE 52 NORTH AMERICA: PROTEIN A RESIN MARKET, BY END USER,
2023–2030 (USD MILLION) 113
TABLE 53 US: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 114
TABLE 54 CANADA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 115
TABLE 55 EUROPE: KEY MACROINDICATORS 116
TABLE 56 EUROPE: PROTEIN A RESIN MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 57 EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 116
TABLE 58 EUROPE: PROTEIN A RESIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 117
TABLE 59 EUROPE: PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2023–2030 (USD MILLION) 117
TABLE 60 EUROPE: PROTEIN A RESIN MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 117
TABLE 61 EUROPE: PROTEIN A RESIN MARKET, BY END USER, 2023–2030 (USD MILLION) 118
TABLE 62 GERMANY: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 118
TABLE 63 UK: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 119
TABLE 64 FRANCE: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 120
TABLE 65 ITALY: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 120
TABLE 66 SPAIN: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 121
TABLE 67 REST OF EUROPE: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 122
TABLE 68 ASIA PACIFIC: KEY MACROINDICATORS 124
TABLE 69 ASIA PACIFIC: PROTEIN A RESIN, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 70 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 124
TABLE 71 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY SOURCE, 2023–2030 (USD MILLION) 125
TABLE 72 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY MATRIX TYPE,
2023–2030 (USD MILLION) 125
TABLE 73 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 125
TABLE 74 ASIA PACIFIC: PROTEIN A RESIN MARKET, BY END USER,
2023–2030 (USD MILLION) 126
TABLE 75 JAPAN: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 126
TABLE 76 CHINA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 127
TABLE 77 INDIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 128
TABLE 78 AUSTRALIA: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 129
TABLE 79 SOUTH KOREA: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 130
TABLE 80 REST OF ASIA PACIFIC: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 131
TABLE 81 LATIN AMERICA: KEY MACROINDICATORS 131
TABLE 82 LATIN AMERICA: PROTEIN A RESIN, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 83 LATIN AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 132
TABLE 84 LATIN AMERICA: PROTEIN A RESIN MARKET, BY SOURCE,
2023–2030 (USD MILLION) 132
TABLE 85 LATIN AMERICA: PROTEIN A RESIN MARKET, BY MATRIX TYPE,
2023–2030 (USD MILLION) 133
TABLE 86 LATIN AMERICA: PROTEIN A RESIN MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 133
TABLE 87 LATIN AMERICA: PROTEIN A RESIN MARKET, BY END USER,
2023–2030 (USD MILLION) 133
TABLE 88 BRAZIL: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 134
TABLE 89 MEXICO: PROTEIN A RESIN MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 135
TABLE 90 REST OF LATIN AMERICA: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 135
TABLE 91 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 136
TABLE 92 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY REGION,
2023–2030 (USD MILLION) 137
TABLE 93 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 137
TABLE 94 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY SOURCE,
2023–2030 (USD MILLION) 137
TABLE 95 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY MATRIX TYPE,
2023–2030 (USD MILLION) 138
TABLE 96 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 138
TABLE 97 MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY END USER,
2023–2030 (USD MILLION) 138
TABLE 98 GCC COUNTRIES: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 139
TABLE 99 REST OF MIDDLE EAST & AFRICA: PROTEIN A RESIN MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 140
TABLE 100 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEIN A RESIN MARKET, 2022–2025 141
TABLE 101 PROTEIN A RESIN MARKET: DEGREE OF COMPETITION 145
TABLE 102 PROTEIN A RESIN MARKET: REGION FOOTPRINT 152
TABLE 103 PROTEIN A RESIN MARKET: PRODUCT FOOTPRINT 152
TABLE 104 PROTEIN A RESIN MARKET: MATRIX TYPE FOOTPRINT 153
TABLE 105 PROTEIN A RESIN MARKET: APPLICATION FOOTPRINT 154
TABLE 106 PROTEIN A RESIN MARKET: END-USER FOOTPRINT 154
TABLE 107 PROTEIN A RESIN MARKET: DETAILED LIST OF KEY STARTUPS/SMES 157
TABLE 108 PROTEIN A RESIN MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, BY PRODUCT AND REGION 158
TABLE 109 PROTEIN A RESIN MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2025 159
TABLE 110 PROTEIN A RESIN MARKET: DEALS, JANUARY 2022–JUNE 2025 159
TABLE 111 PROTEIN A RESIN MARKET: EXPANSIONS, JANUARY 2021–JUNE 2025 160
TABLE 112 DANAHER: COMPANY OVERVIEW 161
TABLE 113 DANAHER: PRODUCTS OFFERED 162
TABLE 114 DANAHER: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 163
TABLE 115 DANAHER: DEALS, JANUARY 2022–JULY 2025 163
TABLE 116 DANAHER: EXPANSIONS, JANUARY 2022–JULY 2025 164
TABLE 117 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 165
TABLE 118 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 166
TABLE 119 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2022–JULY 2025 167
TABLE 120 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS, JANUARY 2022–JULY 2025 167
TABLE 121 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 169
TABLE 122 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 170
TABLE 123 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–JULY 2025 171
TABLE 124 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2022–JULY 2025 171
TABLE 125 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 173
TABLE 126 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 174
TABLE 127 MERCK KGAA: COMPANY OVERVIEW 175
TABLE 128 MERCK KGAA: PRODUCTS OFFERED 176
TABLE 129 MERCK KGAA: EXPANSIONS, JANUARY 2022–JULY 2025 177
TABLE 130 MERCK KGAA: OTHER DEVELOPMENTS, JANUARY 2022–JULY 2025 178
TABLE 131 REPLIGEN CORPORATION: COMPANY OVERVIEW 179
TABLE 132 REPLIGEN CORPORATION: PRODUCTS OFFERED 180
TABLE 133 REPLIGEN CORPORATION: DEALS, JANUARY 2022–JULY 2025 181
TABLE 134 TOSOH BIOSCIENCE: COMPANY OVERVIEW 182
TABLE 135 TOSOH BIOSCIENCE: PRODUCTS OFFERED 183
TABLE 136 TOSOH BIOSCIENCE: EXPANSIONS, JANUARY 2022–JULY 2025 184
TABLE 137 ECOLAB INC.: COMPANY OVERVIEW 185
TABLE 138 ECOLAB INC.: PRODUCTS OFFERED 186
TABLE 139 ECOLAB INC.: PRODUCT LAUNCHES, JANUARY 2022–JULY 2025 187
TABLE 140 ECOLAB INC.: DEALS, JANUARY 2022–JULY 2025 187
TABLE 141 ECOLAB INC.: EXPANSIONS, JANUARY 2022–JULY 2025 187
TABLE 142 NOVOSEP HOLDING: COMPANY OVERVIEW 189
TABLE 143 NOVOSEP HOLDING: PRODUCTS OFFERED 189
TABLE 144 AVANTOR, INC.: COMPANY OVERVIEW 190
TABLE 145 AVANTOR, INC.: PRODUCTS OFFERED 191
TABLE 146 OROCHEM TECHNOLOGIES, INC.: COMPANY OVERVIEW 192
TABLE 147 OROCHEM TECHNOLOGIES, INC.: PRODUCTS OFFERED 192
TABLE 148 KANEKA CORPORATION: COMPANY OVERVIEW 193
TABLE 149 KANEKA CORPORATION: PRODUCTS OFFERED 194
TABLE 150 JSR CORPORATION: COMPANY OVERVIEW 195
TABLE 151 JSR CORPORATION: PRODUCTS OFFERED 196
TABLE 152 GENSCRIPT: COMPANY OVERVIEW 197
TABLE 153 GENSCRIPT: PRODUCTS OFFERED 198
TABLE 154 BIO-WORKS: COMPANY OVERVIEW 199
TABLE 155 GENO TECHNOLOGY, INC.: COMPANY OVERVIEW 199
TABLE 156 PROMEGA CORPORATION: COMPANY OVERVIEW 200
TABLE 157 SUZHOU NANOMICRO TECHNOLOGY CO., LTD.: COMPANY OVERVIEW 200
TABLE 158 TRANSGEN BIOTECH CO., LTD: COMPANY OVERVIEW 201
TABLE 159 RESYN BIOSCIENCES (PTY) LTD: COMPANY OVERVIEW 201
TABLE 160 BIOTOOLOMICS LTD.: COMPANY OVERVIEW 202
TABLE 161 CALIBRE SCIENTIFIC (PROTEIN ARK): COMPANY OVERVIEW 202
TABLE 162 SUNRESIN NEW MATERIALS CO., LTD.: COMPANY OVERVIEW 203
TABLE 163 BEAVER: COMPANY OVERVIEW 203
FIGURE 1 PROTEIN A RESIN MARKET SEGMENTATION & REGIONAL SCOPE 22
FIGURE 2 PROTEIN A RESIN MARKET: RESEARCH DATA 25
FIGURE 3 PROTEIN A RESIN MARKET: RESEARCH DESIGN 26
FIGURE 4 PROTEIN A RESIN MARKET: KEY SECONDARY SOURCES 27
FIGURE 5 PROTEIN A RESIN MARKET: KEY DATA FROM SECONDARY SOURCES 28
FIGURE 6 PROTEIN A RESIN MARKET: KEY PRIMARY SOURCES
(DEMAND AND SUPPLY SIDES) 29
FIGURE 7 PROTEIN A RESIN MARKET: KEY SUPPLY AND DEMAND-SIDE PARTICIPANTS 29
FIGURE 8 PROTEIN A RESIN MARKET: BREAKDOWN OF PRIMARY INTERVIEWS (BY COMPANY TYPE, DESIGNATION, AND REGION) 30
FIGURE 9 PROTEIN A RESIN MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 31
FIGURE 10 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 32
FIGURE 11 PROTEIN A RESIN MARKET: COMPANY REVENUE ESTIMATION 33
FIGURE 12 PROTEIN A RESIN MARKET: END-USER AND REVENUE-MAPPING-BASED MARKET SIZE ESTIMATION METHODOLOGY 34
FIGURE 13 PROTEIN A RESIN MARKET: TOP-DOWN APPROACH 35
FIGURE 14 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS 36
FIGURE 15 PROTEIN A RESIN MARKET: DATA TRIANGULATION METHODOLOGY 38
FIGURE 16 PROTEIN A RESIN MARKET SHARE, BY PRODUCT, 2025 VS. 2030 40
FIGURE 17 PROTEIN A RESIN MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 41
FIGURE 18 PROTEIN A RESIN MARKET, BY MATRIX TYPE, 2025 VS. 2030 (USD MILLION) 42
FIGURE 19 PROTEIN A RESIN MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 42
FIGURE 20 PROTEIN A RESIN MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 43
FIGURE 21 PROTEIN A RESIN MARKET: GEOGRAPHIC SNAPSHOT (2024) 44
FIGURE 22 RISING ADOPTION OF PREPACKED DISPOSABLE COLUMNS TO FUEL MARKET GROWTH 45
FIGURE 23 CHINA AND JAPAN TO ACQUIRE MAJOR SHARES OF ASIA PACIFIC MARKET IN 2024 46
FIGURE 24 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030 47
FIGURE 25 PROTEIN A RESIN MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 48
FIGURE 26 PROTEIN A RESIN MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 52
FIGURE 27 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN,
BY KEY PLAYER, 2022–2024 (USD) 53
FIGURE 28 AVERAGE SELLING PRICE TREND OF PROTEIN A RESIN,
BY REGION, 2022–2024 (USD) 54
FIGURE 29 PROTEIN A RESIN MARKET: VALUE CHAIN ANALYSIS 55
FIGURE 30 PROTEIN A RESIN MARKET: SUPPLY CHAIN ANALYSIS 56
FIGURE 31 PROTEIN A RESIN MARKET: ECOSYSTEM ANALYSIS 58
FIGURE 32 PROTEIN A RESIN MARKET: FUNDING AND NUMBER OF DEALS,
2019–2023 (USD MILLION) 59
FIGURE 33 NUMBER OF DEALS IN PROTEIN A RESIN MARKET, BY KEY PLAYER, 2019–2023 59
FIGURE 34 VALUE OF DEALS IN PROTEIN A RESIN MARKET, BY KEY PLAYER,
2019–2023 (USD) 60
FIGURE 35 PROTEIN A RESIN MARKET: TOP COMPANIES/APPLICANTS FOR PROTEIN A RESIN PATENTS AND NUMBER OF PATENTS GRANTED, 2015–2025 62
FIGURE 36 PROTEIN A RESIN MARKET: IMPORT SCENARIO FOR HS CODE 3504, 2020–2024 63
FIGURE 37 PROTEIN A RESIN MARKET: EXPORT SCENARIO FOR HS CODE 3504, 2020–2024 64
FIGURE 38 PROTEIN A RESIN MARKET: PORTER’S FIVE FORCES ANALYSIS 73
FIGURE 39 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS
FOR PROTEIN A RESIN, BY PRODUCT 75
FIGURE 40 KEY BUYING CRITERIA OF PROTEIN A RESIN, BY END USER 76
FIGURE 41 KEY AI USE CASES IN PROTEIN A RESIN MARKET 80
FIGURE 42 NORTH AMERICA: PROTEIN A RESIN MARKET SNAPSHOT (2024) 110
FIGURE 43 ASIA PACIFIC: PROTEIN A RESIN MARKET SNAPSHOT (2024) 123
FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEIN A RESIN MARKET,
2020–2024 (USD MILLION) 144
FIGURE 45 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PROTEIN A RESIN MARKET, 2024 144
FIGURE 46 MARKET RANKING OF KEY PLAYERS IN PROTEIN A RESIN MARKET, 2024 146
FIGURE 47 EV/EBITDA OF TOP THREE PLAYERS (2025) 146
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF TOP THREE PLAYERS (2025) 147
FIGURE 49 PROTEIN A RESIN MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 148
FIGURE 50 PROTEIN A RESIN MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 150
FIGURE 51 PROTEIN A RESIN MARKET: COMPANY FOOTPRINT 151
FIGURE 52 PROTEIN A RESIN MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 156
FIGURE 53 DANAHER: COMPANY SNAPSHOT 162
FIGURE 54 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 166
FIGURE 55 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT 170
FIGURE 56 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 174
FIGURE 57 MERCK KGAA: COMPANY SNAPSHOT (2024) 176
FIGURE 58 REPLIGEN CORPORATION: COMPANY SNAPSHOT (2024) 180
FIGURE 59 TOSOH BIOSCIENCE: COMPANY SNAPSHOT (2024) 183
FIGURE 60 ECOLAB INC.: COMPANY SNAPSHOT (2024) 186
FIGURE 61 AVANTOR, INC.: COMPANY SNAPSHOT (2024) 191
FIGURE 62 KANEKA CORPORATION: COMPANY SNAPSHOT (2024) 193
FIGURE 63 JSR CORPORATION: COMPANY SNAPSHOT (2024) 196
FIGURE 64 GENSCRIPT: COMPANY SNAPSHOT (2024) 198